Key facts
- Notable investors include MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg, S Wagnis-und Beteiligungskapital, S-Kap Unternehmensbeteiligungs.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for OrangeCAD MED
- ·The full record, as it builds
Funding rounds
No funding rounds for OrangeCAD MED are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OrangeCAD MED
Manufacturer of precision medical implant components designed for dental practitioners and laboratories. The company offers CAD/CAM-compatible prosthetic parts, such as titanium bases, abutments, impression posts, and lab analogs, with universal compatibility, enabling dental professionals worldwide to integrate reliable components seamlessly into their existing workflows.
- Sector
- Healthcare
- HQ
- Karlsruhe, Germany
- Founded
- 2021
- Employees
- 11
- Website
- orangecad-med.com/
- Ownership
- Privately Held (backing)
OrangeCAD MED doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OrangeCAD MED shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OrangeCAD MED in its N-PORT filings yet. We sweep new filings monthly.